Rosenblatt analyst Mike Genovese raised the firm’s price target on Lumentum (LITE) to $1,300 from $900 and keeps a Buy rating on the shares. Lumentum looks to be on track to make or exceed its target of hitting $1.25B in quarterly sales by the end of calendar 2026 and $2B in quarterly sales by the end of 2027, notes the analyst, who adds that margins appear to be tracking ahead of targets.
Meet Samuel – Your Personal Investing Prophet
Double your LITE exposure with Tradr's LITXPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LITE:
- Needham’s O’Loughlin Maintains Hold on Lumentum but Lifts Price Target to $995 Amid Strong Demand Outpacing Capacity
- Lumentum reports Q3 adjusted EPS $2.37, consensus $2.27
- Lumentum sees Q4 adjusted EPS $2.85-$3.05, consensus $2.69
- Notable companies reporting after market close
- Lumentum options imply 9.9% move in share price post-earnings